Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · IEX Real-Time Price · USD
2.120
-0.240 (-10.17%)
At close: Jul 17, 2024, 4:00 PM
2.190
+0.070 (3.30%)
After-hours: Jul 17, 2024, 5:42 PM EDT

Amylyx Pharmaceuticals Market Cap

Amylyx Pharmaceuticals has a market cap or net worth of $144.17 million as of July 17, 2024. Its market cap has decreased by -90.05% in one year.

Market Cap
144.17M
Enterprise Value
-225.13M
1-Year Change
-90.05%
Ranking
Category
Stock Price
$2.12

Market Cap Chart

Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $144.17M, a decrease of -86.52%. That is a compound annual growth rate of -54.80%.

History

DateMarket Cap% Change
Jul 16, 2024160.50M-83.85%
Dec 29, 2023993.90M-59.40%
Dec 30, 20222.45B128.98%
Jan 7, 20221.07B-
View and export this data all the way back to 2022. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Zomedica 149.05M
Compass Therapeutics 148.60M
Repare Therapeutics 147.71M
Cardiol Therapeutics 146.97M
InfuSystem Holdings 146.94M
Invivyd 141.99M
DIH Holdings US 141.91M
Harvard Bioscience 141.58M
Market Cap Rankings